Filing metadata

Accession number
0001104659-23-008077
Form type
Form 4
Filer
RVL Pharmaceuticals plc
CIK
CIK 1739426
Filed
Jan 30, 2023
Reporting period
Jan 27, 2023
Description
Insider transaction

Explore SEC Filings Hub